Protagenic Therapeutics, Inc.\new Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation
Protagenic Therapeutics, Inc.\new (PTIX) reported Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation of $86.97 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation · last filed 2020-08-14
- Protagenic Therapeutics, Inc.\new adjustments to additional paid in capital, income tax deficiency from share-based compensation for the quarter ending 2020-06-30 was $86.97K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation 3 month |
|---|---|
| 2020-06-30 | $86.97K 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |